Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ELMD
ELMD logo

ELMD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Electromed Inc (ELMD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
26.390
1 Day change
3.57%
52 Week Range
30.730
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Electromed Inc (ELMD) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has strong financial growth, positive analyst ratings, and a bullish technical setup. Despite the lack of recent news or significant trading trends, the positive financial performance and raised price target by analysts make this a solid long-term investment opportunity.

Technical Analysis

The stock shows a bullish trend with MACD above 0 and positively contracting, RSI in the neutral zone at 55.294, and moving averages aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 25.264, with resistance at 26.159 and support at 24.369.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
11

Positive Catalysts

  • Raised price target by Roth Capital to $38 from $36, driven by strong performance in the core homecare business. Financials show significant YoY growth in revenue, net income, and EPS.

Neutral/Negative Catalysts

  • No significant news or trading trends from hedge funds, insiders, or Congress. Lack of recent AI Stock Picker or SwingMax signals.

Financial Performance

In Q2 2026, revenue increased by 16.25% YoY to $18,897,000, net income rose by 40.29% YoY to $2,761,000, EPS grew by 45.45% YoY to 0.32, and gross margin improved to 78.42%, up 0.95% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Roth Capital maintains a Buy rating and raised the price target to $38 from $36, citing above-expectation results driven by strong performance in the core homecare business.

Wall Street analysts forecast ELMD stock price to rise
3 Analyst Rating
Wall Street analysts forecast ELMD stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 25.480
sliders
Low
36
Averages
37.33
High
38
Current: 25.480
sliders
Low
36
Averages
37.33
High
38
Roth Capital
Buy
maintain
$36 -> $38
AI Analysis
2026-02-11
Reason
Roth Capital
Price Target
$36 -> $38
AI Analysis
2026-02-11
maintain
Buy
Reason
Roth Capital raised the firm's price target on Electromed to $38 from $36 and keeps a Buy rating on the shares. The company reported results that were above expectations, largely driven by strong performance in the company's core homecare business, the analyst tells investors in a research note.
Roth Capital
Buy
maintain
$35 -> $36
2025-11-13
Reason
Roth Capital
Price Target
$35 -> $36
2025-11-13
maintain
Buy
Reason
Roth Capital raised the firm's price target on Electromed to $36 from $35 and keeps a Buy rating on the shares. The company's Q1 results were above expectations and the management reiterated its goal to drive double-digit top-line growth and expanded operating leverage, the analyst tells investors in a research note. The company's best-in-class high frequency chest wall oscillation device continues to take share in a highly underdiagnosed bronchiectasis market, the firm added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ELMD
Unlock Now

People Also Watch